Product Images Lurasidone Hydrochloride

This text provides information on the impact of different drugs on the pharmacokinetics of Lurasidone. It lists the fold change and 90% confidence interval for various drugs classified as strong CYP3A4 inhibitors, moderate CYP3A4 inhibitors, and strong CYP3A4 inducers. The text also mentions specific drugs and their dosages, such as Ketoconazole, Diltiazem, Rifampin, and Lithium, and their effects on Cmax and AUC values of Lurasidone. The data indicates changes in Cmax and AUC relative to Lurasidone when each drug is present.*

This document lists the PK fold change and 90% confidence intervals for the interaction of various drugs with P-gp substrates, CYP3A4 substrates, oral contraceptives, and lithium. The listed drugs include Digoxin, Midazolam, Ethinyl Estradiol, Norelgestromin, and Lithium. The data shows changes in Cmax and AUC for each drug interaction.*

This text provides information on renal and hepatic impairment levels (mild, moderate, severe), population descriptions (gender, race), and comparisons between Asian and Caucasian races in terms of PK, Fold Change, and 90% CI. It also mentions "Change relative to reference" but does not offer a detailed explanation.*

Each film-coated tablet contains Lurasidone Hydrochloride 20 mg (equivalent to 18.62 mg of lurasidone). The usual dosage instructions can be found in the package insert. Store the tablets at 20° to 25°C (68° to 77°F). The medication is dispensed along with a medication guide provided separately to each patient by the pharmacist. This product is manufactured by Macleods Pharmaceuticals Ltd in India. The tablets have an NDC code of 72603-621-01. For more information, visit www.northstarnic.com/products or call 1-800-206-7821.*

Each film-coated tablet of Lurasidone Hydrochloride 40 mg is equivalent to 37.24 mg of lurasidone. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication is dispensed with a pharmacist-provided medication guide and packaged in a container with 30 tablets. For more information, visit the manufacturer's website or call the listed phone number. This product is from NorthStar Healthcare Holdings Ltd, manufactured by Macleods Pharmaceuticals Ltd in India.*

This is a description of a medication with NDC code 72603-623-01, containing Lurasidone Hydrochloride Tablets of 60 mg. The tablets are film-coated and each tablet contains 60 mg of Lurasidone Hydrochloride. The usual dosage information can be found in the package insert. The medication should be stored at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). Manufactured for NorthStar Rx LLC, the medication is set to expire in September 2024. For more information, a medication guide is available at the website www.northstarnic.com/products or by calling 1-800-206-7821.*

Each film-coated tablet contains Lurasidone Hydrochloride 80 mg. The recommended dosage can be found in the package insert. Store between 20° to 25°C (68° to 77°F). For more information, visit the medical guide available at NorthStar.com or call 1-800-206-7821. This product is manufactured by Mackeods Pharmaceuticals Ltd.*